(de-nh2)phe(19)-ala(24)-pro(26)psi(ch2nh)-phe(27)-grp (19-27) has been researched along with Pancreatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, YS; Kull, FC; Leban, JJ; Singh, P | 1 |
1 other study(ies) available for (de-nh2)phe(19)-ala(24)-pro(26)psi(ch2nh)-phe(27)-grp (19-27) and Pancreatic Neoplasms
Article | Year |
---|---|
A novel bombesin receptor antagonist (2258U89), potently inhibits bombesin evoked release of gastrointestinal hormones from rats and dogs, in vitro and in vivo.
Topics: Animals; Bombesin; Dogs; Female; Gastrins; Gastrointestinal Hormones; In Vitro Techniques; Insulin; Kinetics; Male; Oligopeptides; Pancreatic Neoplasms; Pancreatic Polypeptide; Radioligand Assay; Rats; Receptors, Bombesin; Receptors, Neurotransmitter; Tumor Cells, Cultured | 1992 |